China Premenstrual Syndrome Medicine Market Research Report 2018

February 2018 | 95 pages | ID: C6D3F619E26EN
QYResearch

Abstracts

The global Premenstrual Syndrome Medicine market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Premenstrual Syndrome Medicine development status and future trend in China, focuses on top players in China, also splits Premenstrual Syndrome Medicine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include

• Asarina Pharma AB
• Pherin Pharmaceuticals Inc

Geographically, this report splits the China market into six regions,

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into

• PH-80PMD
• Estrogen
• Progesterone
• Others

On the basis of the end users/application, this report covers

• Home Care
• Hospital
• Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

China Premenstrual Syndrome Medicine Market Research Report 2018

1 PREMENSTRUAL SYNDROME MEDICINE OVERVIEW

1.1 Product Overview and Scope of Premenstrual Syndrome Medicine
1.2 Classification of Premenstrual Syndrome Medicine by Product Category
  1.2.1 China Premenstrual Syndrome Medicine Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 China Premenstrual Syndrome Medicine Sales (K Pcs) Market Share by Type in 2017
  1.2.3 PH-80PMD
  1.2.4 Estrogen
  1.2.5 Progesterone
  1.2.6 Others
1.3 China Premenstrual Syndrome Medicine Market by Application/End Users
  1.3.1 China Premenstrual Syndrome Medicine Sales (K Pcs) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Home Care
  1.3.3 Hospital
  1.3.4 Clinic
1.4 China Premenstrual Syndrome Medicine Market by Region
  1.4.1 China Premenstrual Syndrome Medicine Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.3 East China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.4 Southwest China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.5 Northeast China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.6 North China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
  1.4.7 Central China Premenstrual Syndrome Medicine Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Premenstrual Syndrome Medicine (2013-2025)
  1.5.1 China Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.5.2 China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA PREMENSTRUAL SYNDROME MEDICINE MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Premenstrual Syndrome Medicine Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Premenstrual Syndrome Medicine Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Premenstrual Syndrome Medicine Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 China Premenstrual Syndrome Medicine Market Competitive Situation and Trends
  2.4.1 China Premenstrual Syndrome Medicine Market Concentration Rate
  2.4.2 China Premenstrual Syndrome Medicine Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Premenstrual Syndrome Medicine Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA PREMENSTRUAL SYNDROME MEDICINE SALES AND REVENUE BY REGION (2013-2018)

3.1 China Premenstrual Syndrome Medicine Sales (K Pcs) and Market Share by Region (2013-2018)
3.2 China Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Premenstrual Syndrome Medicine Price (USD/Pcs) by Regions (2013-2018)

4 CHINA PREMENSTRUAL SYNDROME MEDICINE SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Premenstrual Syndrome Medicine Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
4.2 China Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Premenstrual Syndrome Medicine Price (USD/Pcs) by Type (2013-2018)
4.4 China Premenstrual Syndrome Medicine Sales Growth Rate (%) by Type (2013-2018)

5 CHINA PREMENSTRUAL SYNDROME MEDICINE SALES BY APPLICATION (2013-2018)

5.1 China Premenstrual Syndrome Medicine Sales (K Pcs) and Market Share by Application (2013-2018)
5.2 China Premenstrual Syndrome Medicine Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA PREMENSTRUAL SYNDROME MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Asarina Pharma AB
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Premenstrual Syndrome Medicine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Pherin Pharmaceuticals Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Premenstrual Syndrome Medicine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview

7 PREMENSTRUAL SYNDROME MEDICINE MANUFACTURING COST ANALYSIS

7.1 Premenstrual Syndrome Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Premenstrual Syndrome Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Premenstrual Syndrome Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Premenstrual Syndrome Medicine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA PREMENSTRUAL SYNDROME MEDICINE MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
11.2 China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Type (2018-2025)
11.3 China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Application (2018-2025)
11.4 China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Premenstrual Syndrome Medicine Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Premenstrual Syndrome Medicine Sales (K Pcs) by Application (2013-2025)
Figure Product Picture of Premenstrual Syndrome Medicine
Table China Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Market Share by Types in 2017
Figure PH-80PMD Product Picture
Figure Estrogen Product Picture
Figure Progesterone Product Picture
Figure Others Product Picture
Figure China Premenstrual Syndrome Medicine Sales (K Pcs) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Premenstrual Syndrome Medicine by Application in 2017
Figure Home Care Examples
Table Key Downstream Customer in Home Care
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure South China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Premenstrual Syndrome Medicine Sales of Key Players/Manufacturers (2013-2018)
Table China Premenstrual Syndrome Medicine Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Premenstrual Syndrome Medicine Sales Share (%) by Players/Manufacturers
Figure 2017 China Premenstrual Syndrome Medicine Sales Share (%) by Players/Manufacturers
Table China Premenstrual Syndrome Medicine Revenue by Players/Manufacturers (2013-2018)
Table China Premenstrual Syndrome Medicine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Premenstrual Syndrome Medicine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Premenstrual Syndrome Medicine Revenue Market Share (%) by Players/Manufacturers
Table China Market Premenstrual Syndrome Medicine Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Premenstrual Syndrome Medicine Average Price of Key Players/Manufacturers in 2017
Figure China Premenstrual Syndrome Medicine Market Share of Top 3 Players/Manufacturers
Figure China Premenstrual Syndrome Medicine Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Premenstrual Syndrome Medicine Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Premenstrual Syndrome Medicine Product Category
Table China Premenstrual Syndrome Medicine Sales (K Pcs) by Regions (2013-2018)
Table China Premenstrual Syndrome Medicine Sales Share (%) by Regions (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Share (%) by Regions (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Market Share (%) by Regions in 2017
Table China Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Premenstrual Syndrome Medicine Revenue Market Share (%) by Regions (2013-2018)
Figure China Premenstrual Syndrome Medicine Revenue Market Share (%) by Regions (2013-2018)
Figure China Premenstrual Syndrome Medicine Revenue Market Share (%) by Regions in 2017
Table China Premenstrual Syndrome Medicine Price (USD/Pcs) by Regions (2013-2018)
Table China Premenstrual Syndrome Medicine Sales (K Pcs) by Type (2013-2018)
Table China Premenstrual Syndrome Medicine Sales Share (%) by Type (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Share (%) by Type (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Market Share (%) by Type in 2017
Table China Premenstrual Syndrome Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Premenstrual Syndrome Medicine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Premenstrual Syndrome Medicine by Type (2013-2018)
Figure Revenue Market Share of Premenstrual Syndrome Medicine by Type in 2017
Table China Premenstrual Syndrome Medicine Price (USD/Pcs) by Types (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Growth Rate (%) by Type (2013-2018)
Table China Premenstrual Syndrome Medicine Sales (K Pcs) by Applications (2013-2018)
Table China Premenstrual Syndrome Medicine Sales Market Share (%) by Applications (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Market Share (%) by Application (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Market Share (%) by Application in 2017
Table China Premenstrual Syndrome Medicine Sales Growth Rate (%) by Application (2013-2018)
Figure China Premenstrual Syndrome Medicine Sales Growth Rate (%) by Application (2013-2018)
Table Asarina Pharma AB Premenstrual Syndrome Medicine Basic Information List
Table Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Sales Market Share (%) in China (2013-2018)
Figure Asarina Pharma AB Premenstrual Syndrome Medicine Revenue Market Share (%) in China (2013-2018)
Table Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Basic Information List
Table Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Sales Market Share (%) in China (2013-2018)
Figure Pherin Pharmaceuticals Inc Premenstrual Syndrome Medicine Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Premenstrual Syndrome Medicine
Figure Manufacturing Process Analysis of Premenstrual Syndrome Medicine
Figure Premenstrual Syndrome Medicine Industrial Chain Analysis
Table Raw Materials Sources of Premenstrual Syndrome Medicine Major Players/Manufacturers in 2017
Table Major Buyers of Premenstrual Syndrome Medicine
Table Distributors/Traders List
Figure China Premenstrual Syndrome Medicine Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure China Premenstrual Syndrome Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Premenstrual Syndrome Medicine Price (USD/Pcs) Trend Forecast (2018-2025)
Table China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Type (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Market Share Forecast by Type in 2025
Table China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Application (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Market Share Forecast by Application in 2025
Table China Premenstrual Syndrome Medicine Sales (K Pcs) Forecast by Regions (2018-2025)
Table China Premenstrual Syndrome Medicine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Share Forecast by Regions (2018-2025)
Figure China Premenstrual Syndrome Medicine Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources